IL93164A0 - Purine nucleosides and their medical use - Google Patents

Purine nucleosides and their medical use

Info

Publication number
IL93164A0
IL93164A0 IL93164A IL9316490A IL93164A0 IL 93164 A0 IL93164 A0 IL 93164A0 IL 93164 A IL93164 A IL 93164A IL 9316490 A IL9316490 A IL 9316490A IL 93164 A0 IL93164 A0 IL 93164A0
Authority
IL
Israel
Prior art keywords
aica riboside
medical use
prodrugs
purine nucleosides
blood glucose
Prior art date
Application number
IL93164A
Other languages
English (en)
Original Assignee
Gensia Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/301,453 external-priority patent/US5200525A/en
Priority claimed from US07/301,222 external-priority patent/US5082829A/en
Application filed by Gensia Pharma filed Critical Gensia Pharma
Publication of IL93164A0 publication Critical patent/IL93164A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
IL93164A 1989-01-24 1990-01-24 Purine nucleosides and their medical use IL93164A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/301,453 US5200525A (en) 1989-01-24 1989-01-24 Anti-seizure compounds
US07/301,222 US5082829A (en) 1989-01-24 1989-01-24 AICA riboside prodrugs
US40810789A 1989-09-15 1989-09-15

Publications (1)

Publication Number Publication Date
IL93164A0 true IL93164A0 (en) 1990-11-05

Family

ID=27404800

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93164A IL93164A0 (en) 1989-01-24 1990-01-24 Purine nucleosides and their medical use

Country Status (13)

Country Link
EP (1) EP0427799B1 (de)
JP (1) JPH03504728A (de)
KR (1) KR910700057A (de)
AT (1) ATE114474T1 (de)
AU (2) AU5086190A (de)
CA (1) CA2008325A1 (de)
DE (1) DE69014562T2 (de)
DK (1) DK0427799T3 (de)
FI (1) FI904694A0 (de)
IE (1) IE75372B1 (de)
IL (1) IL93164A0 (de)
NO (1) NO904149L (de)
WO (1) WO1990009163A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214048A (en) * 1987-05-19 1993-05-25 Nippon Kayaku Kabushiki Kaisha Oxetanocins
US7776838B1 (en) 1987-10-28 2010-08-17 Wellstat Therapeutics Corporation Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5736531A (en) * 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US5968914A (en) 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5202459A (en) * 1989-11-07 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for producing cyclobutane derivative
JPH0615556B2 (ja) * 1989-11-10 1994-03-02 旭化成工業株式会社 ４―カルバモイル―１―β―Ｄ―リボフラノシル―イミダゾリウム―５―オレイト無水結晶
US5324730A (en) * 1990-05-24 1994-06-28 Nippon Kayaku Kabushiki Kaisha Phenoxyphosphoryloxymethyl cyclobutyl purines
IL99124A (en) * 1990-08-10 1998-02-22 Gensia Pharma Substituted imidazole analogs of aica riboside
US5236908A (en) * 1991-06-07 1993-08-17 Gensia Pharmaceuticals, Inc. Methods of treating injury to the central nervous system
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
IL108523A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
RU2153873C2 (ru) * 1994-08-09 2000-08-10 Кортендо АБ Применение кетоконазола и родственных веществ в лекарствах, предназначенных для лечения диабета типа ii
WO1998039342A1 (en) 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
EP1402895A1 (de) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazolinhibitoren der Fructose 1,6-biphosphatase
WO1998039344A1 (en) 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
ZA981936B (en) 1997-03-07 1999-09-06 Metabasis Therapeutics Inc Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
US6312662B1 (en) 1998-03-06 2001-11-06 Metabasis Therapeutics, Inc. Prodrugs phosphorus-containing compounds
CN1900087A (zh) * 1998-09-09 2007-01-24 症变治疗公司 新的果糖1,6－二磷酸酶的杂芳族抑制剂
AU2003242500B2 (en) * 1998-09-09 2006-11-02 Metabasis Therapeutics, Inc. Novel Heteroaromatic Inhibitors of Fructose 1,6-bisphosphatase
WO2000014095A1 (en) 1998-09-09 2000-03-16 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
RU2227749C2 (ru) * 1998-12-24 2004-04-27 Метабэйсис Терапьютикс, Инк. Комбинация ингибиторов fbpазы и сенсибилизаторов инсулина для лечения диабета
KR20020079988A (ko) 2000-03-08 2002-10-21 메타베이시스 테라퓨틱스, 인크. 신규한 아릴 프럭토스-1,6-비스포스파타제 억제제
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
HUP0301830A3 (en) * 2000-07-06 2007-10-29 Metabasis Therapeutics Inc Pharmaceutical composition containing a combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
EP1752450A1 (de) 2005-08-01 2007-02-14 Merck Sante Imidazolderivate als Fruktose-1,6-biphosphataseinhibitoren und pharmazeutische Zusammensetzungen diese enthaltend
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
EP2058308A1 (de) 2007-11-12 2009-05-13 Merck Sante Benzimidazoldihydrothiadiazinonderivate als Fructose-1,6-biphosphatase-Hemmer und diese enthaltende pharmazeutische Zusammensetzungen.
WO2010040110A1 (en) * 2008-10-03 2010-04-08 Pericor Therapeutics, Inc. Methods and compositions for treatment of acute heart failure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1535561A (fr) * 1966-06-18 1968-08-09 Ajinomoto Kk Méthode de préparation de l'adénine, de ses dérivés et intermédiaires
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
ATE135914T1 (de) * 1986-03-27 1996-04-15 Gensia Inc Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.

Also Published As

Publication number Publication date
EP0427799B1 (de) 1994-11-30
KR910700057A (ko) 1991-03-13
DE69014562D1 (de) 1995-01-12
DE69014562T2 (de) 1995-06-22
ATE114474T1 (de) 1994-12-15
AU5086190A (en) 1990-09-05
EP0427799A4 (en) 1991-07-24
FI904694A7 (fi) 1990-09-24
NO904149D0 (no) 1990-09-24
IE75372B1 (en) 1997-09-10
AU5236093A (en) 1994-02-24
WO1990009163A3 (en) 1991-01-24
WO1990009163A2 (en) 1990-08-23
EP0427799A1 (de) 1991-05-22
DK0427799T3 (da) 1995-05-08
JPH03504728A (ja) 1991-10-17
FI904694A0 (fi) 1990-09-24
IE900274L (en) 1990-07-24
NO904149L (no) 1990-11-26
CA2008325A1 (en) 1990-07-24

Similar Documents

Publication Publication Date Title
KR910700057A (ko) Aica리보시드 전달 및 혈당을 저하시키기 위한 방법 및 화합물
CA2005815A1 (en) Antiviral acyclic nucleoside derivatives
EA199800009A1 (ru) Ингибиторы аденозинкиназы, модифицированные по атому с-4′
AU1259288A (en) Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)
UA29382C2 (uk) Карбоциклічні нуклеозиди 6-заміщеного пурину
CA2033044A1 (en) 6-substituted purine carbocyclic nucleosides
EP0306347A3 (en) Diagnosis and treatment of double-stranded rna deficiency states
CA2009579A1 (en) Insulin analogs
WO2000030629A3 (en) Method of promoting cervical and vaginal secretions
EP0354322A3 (de) Antidiabetische alpha-substituierte Phosphonate
EP0288847A3 (en) Continuous process for the epimerization of sugars, in particular of d-arabinose into d-ribose
GR3024699T3 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections.
GB9112420D0 (en) Treatment of disease associated with hiv-infections
HUT47432A (en) Process for correcting disorders of immun-complexes of the circulation systhem and monocytes with double-line dns
HRP20030928A2 (en) Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
ZA975028B (en) Finger-pressure functioning health-aid instrument for improving blood circulation in the human body.
IE892654L (en) Therapeutic nucleosides
AU2390188A (en) Treatment of diseases caused by viruses
EP0797440A4 (de) Die behandlung von autoimmunkrankheiten mit hilfe von 2-aminopurinderivaten
DK688787D0 (da) Indretning ved stol, udstyret med omstilbar laegstoettedel
Najim et al. Benzodiazepine-induced hyperglycemia.
JPS6445314A (en) Antitumoral
EP0311467A3 (en) Use of pyrroloû3,2,1-hi¨indole derivatives in the manufacture of a medicament for the treatment of diabetes
EP0516186A3 (en) Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
Adjei Experimental cancer chemotherapy with cytotoxic nucleosides and nucleoside transport inhibitors